ECTRIMS 2024: Simvastatin fails to slow disability progression in SPMS - Multiple Sclerosis News Today

Daily treatment with high-dose simvastatin, a widely used cholesterol-lowering medication, failed to slow disability progression in adults with secondary progressive disease or SPMS, according to top… [+4973 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute